Notices of Funding Opportunities (NOFOs)
| Title | Announcement Number | Opening Date | Expiration Date | Activity Code |
|---|---|---|---|---|
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) | RFA-CA-25-007 | 03/04/2025 | 10/04/2025 | P50 |
| Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) | RFA-CA-25-006 | 03/04/2025 | 10/04/2025 | U01 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) | RFA-CA-25-005 | 03/04/2025 | 10/04/2025 | R01 |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | RFA-CA-25-004 | 03/04/2025 | 10/04/2025 | R33 |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | RFA-CA-25-003 | 03/04/2025 | 10/04/2025 | R61 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | RFA-CA-25-002 | 03/04/2025 | 10/04/2025 | R33 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | RFA-CA-25-001 | 03/04/2025 | 10/04/2025 | R61 |
| Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed) | PAR-25-119 | 01/14/2025 | 10/24/2025 | U01 |
| Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed) | PAR-25-118 | 01/14/2025 | 10/24/2025 | UH2 |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) | PAR-25-044 | 01/16/2025 | 01/08/2028 | R21 |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) | PAR-25-043 | 01/05/2025 | 01/08/2028 | R01 |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | 11/04/2024 | 12/05/2026 | R50 |
| Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) | PAR-25-415 | 08/09/2025 | 09/08/2028 | R16 |
| Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) | PAR-25-414 | 08/29/2025 | 09/08/2028 | R16 |
| Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) | PAR-24-311 | 01/05/2025 | 01/08/2028 | R01 |
| Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) | PAR-24-306 | 01/05/2025 | 09/08/2026 | R01 |
| Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed) | PAR-25-214 | 01/15/2025 | 01/08/2026 | R21 |
DCB-Supported NIH Highlighted Topics
NIH Highlighted Topics inform the research community about particular areas of science of interest to NIH. Below are some of DCB's latest scientific interests: